Physician profile
Hilda E Rodriguez
NPI 1558419549
$3,749.52
in general payments reported to CMS, 2019-2025
31 companies · $789 in 2025
The $789 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $226 · 2021: $257 · 2022: $1,072 · 2023: $683 · 2024: $264 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,736.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $490.56 | 2021-2025 | Nexplanon |
| Novo Nordisk INC | $326.71 | 2022-2025 | Wegovy, Saxenda |
| Mayne Pharma Commercial LLC | $295.54 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $244.50 | 2019-2025 | |
| Abbvie INC. | $224.17 | 2020-2023 | Liletta |
| Allergan, INC. | $186.42 | 2019-2020 | |
| Astellas Pharma US INC | $184.49 | 2019-2025 | Veozah |
| Baxter Healthcare | $176.26 | 2019-2025 | Perclot |
| Exact Sciences Corporation | $171.22 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Medtronic, INC. | $166.63 | 2022 | |
| Boston Scientific Corporation | $161.56 | 2020-2025 | Solyx Sis System |
| Evofem Biosciences, INC. | $141.90 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $115.54 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $105.42 | 2022 | |
| Aspira Women'S Health INC | $87.26 | 2021-2024 | Ova1 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $84.86 | 2019-2025 | Slynd |
| Pfizer INC. | $77.86 | 2022 | |
| Hologic Sales and Service, LLC | $73.79 | 2022-2023 | Aptima |
| Ascend Therapeutics US, LLC | $71.30 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $65.03 | 2019-2020 | |
| Agile Therapeutics, INC. | $48.99 | 2023-2024 | Twirla |
| Currax Pharmaceuticals LLC | $48.07 | 2025 | Contrave |
| Ethicon US, LLC | $38.92 | 2019-2024 | Vistaseal |
| Coopersurgical, INC. | $30.20 | 2022-2023 | Paragard T 380a |
| Lupin INC. | $26.89 | 2019 | |
| Conmed Corporation | $24.29 | 2023 | Airseal |
| Millicent US INC | $21.48 | 2025 | Femlyv |
| Avion Pharmaceuticals | $21.33 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.99 | 2022 | |
| Meditrina | $12.79 | 2024 | |
| Dysis Medical, INC. | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilda Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.